Page last updated: 2024-08-23

idarubicin and Cells, Neoplasm Circulating

idarubicin has been researched along with Cells, Neoplasm Circulating in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crooks, RL; Granter, N; Lincz, LF; Spencer, A; Way, SL1

Trials

1 trial(s) available for idarubicin and Cells, Neoplasm Circulating

ArticleYear
Tumour kinetics in multiple myeloma before, during, and after treatment.
    Leukemia & lymphoma, 2001, Volume: 40, Issue:3-4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Cell Count; Cell Division; Cyclophosphamide; Dexamethasone; Female; Gene Rearrangement; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunoglobulin Heavy Chains; Kinetics; Leukapheresis; Male; Middle Aged; Molecular Sequence Data; Multiple Myeloma; Neoplasm, Residual; Neoplastic Cells, Circulating; Transplantation, Autologous

2001